Data Supplement from Neutralizing Murine TGFβR2 Promotes a Differentiated Tumor Cell Phenotype and Inhibits Pancreatic Cancer Metastasis

Authors:
  • KOKatherine T. Ostapoff
    Katherine T. Ostapoff
  • BCBercin Kutluk Cenik
    Bercin Kutluk Cenik
  • MWMiao Wang
    Miao Wang
  • RYRisheng Ye
    Risheng Ye
  • XXXiaohong Xu
    Xiaohong Xu
  • DNDesiree Nugent
    Desiree Nugent
  • MHMoriah M. Hagopian
    Moriah M. Hagopian
  • MTMary Topalovski
    Mary Topalovski
  • LRLee B. Rivera
    Lee B. Rivera
  • KCKyla D. Carroll
    Kyla D. Carroll
  • RBRolf A. Brekken
    Rolf A. Brekken

Abstract
Supplemental Figures S1-S12. 2G8 does not bind to human TGFβR2 (S1); 2G8 treated stromal cells do not induce tumor cell proliferation (S2); 2G8 inhibits smad2 dependent signaling in a dose dependent fashion (S3); Tgfβr2 inhibition induces apoptosis and inhibits proliferation in a murine transgenic model of PDAC (S4); Tgfβr2 inhibition reduces perfusion and permeability in KIC tumors (S5); Collagen deposition and fibroblast infiltration is reduced after Tgfβr2 inhibition in PDAC (S6); 2G8 preserves M1 macrophage phenotype in the presence of exogenous TGF-β (S7); 2G8 promotes a proinflammatory immune cell phenotype in an immunocompetent model of PDAC (S8); 2G8 reduces metastatic burden in KIC mice (S9); 2G8 inhibition of tumor cell Tgfβr2 alone is insufficient to alter tumor cell epithelial/mesenchymal phenotype in vitro (S10); 2G8 inhibits EMT in multiple in vivo human xenograft models (S11); Cytokine changes in stromal cells in vitro after inhibition of Tgfβr2 (S12).